Abstract
Intraventricular administration of 6-hydroxydopamine produced a relatively small decline in tyrosine hydroxylase (TH) activity in rat hippocampus despite the widespread degeneration of central noradrenergic nerve terminals. This increase in the ratio of TH activity to norepinephrine content appeared to result from two temporally distinct processes. At first, within 36 hours after the lesion, the apparent Vmax of TH decreased in parallel to the loss of norepinephrine but there was a marked increase in the affinity of the enzyme for cofactor, resembling the effects of in vitro phosphorylation. Subsequently, this activation of the enzyme declined but the apparent Vmax of TH gradually increased in a manner suggesting an increase in the amount of TH per residual terminal. These short and long term alterations in TH activity after 6-hydroxydopamine treatment may represent adaptive responses to the lesion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acheson, A.L., Kapatos, G. and Zigmond, M.J. (1981) Life Sci., 28. 1407–1420.
Acheson, A.L., Zigmond, M.J. and Stricker, E.M. (1979) Trans. Amer. Soc. Neurochem., 10, 142.
Acheson, A.L., Zigmond, M.J. and Stricker, E.M. (1980) Science, 207, 537–540.
Acheson, A.L. and Zigmond, M.J. (1981) J. Neurosci., in press.
Buda, M., Roussel, B., Renaud, B. and Pujol, J.F. (1975) Brain Res., 93, 564–569
Cannon, W.B., Newton, H.F., Bright, E.M., Menkin, V. and Moore, R.M. (1929) Amer. J. Physiol., 89, 84–107.
Cedarbaum, J.M. and Aghajanian, G.K. (1976) Brain Res., 112, 413–419.
Gauthier, P., Nadeau, R.A. and deChamplain (1972) Circ. Res., 31, 207–217.
Hornykiewicz, O. (1973) Biochem. Pharmacol., 24, 1061–1065.
Kapatos, G. and Zigmond, M.J. (1979) J. Pharmacol. Exp. Therap., 208, 468–475.
Lloyd, K.G., Davidson, L. and Hornykiewicz, O. (1975) J. Pharmacol. Exp. Therap., 195, 453–464.
Lloyd, T. and Kaufman, S. (1974) Biochem. Biophys. Res. Commun., 59, 1262–1269.
Morgenroth, V.H., Boadle-Biber, M. and Roth, R.H. (1974) Proc. Natl. Acad. Sci. USA, 71, 4283–4287.
Roth, R.H., Salzman, P.M. and Morgenroth, V.H. (1974) Biochem. Pharmacol., 23, 2779–2784.
Saller, C.F. and Zigmond, M.J. (1978) Life Sciences, 23, 1117–1130.
Stricker, E.M. and Zigmond, M.J. (1976) Progress in Psychobiology and Physiological Psychology Vol. 6, ed. by J.M. Sprague and A.N. Epstein, Academic Press, Inc., New York. pp. 121–188.
Thoenen, H., Mueller, R.A. and Axelrod, J. (1969) J. Pharmacol. Exn. Therap.. 169. 249–254.
Uretsky, N.J. and Iversen, L.L. (1970) J. Neurochem., 17, 269–278.
Zigmond, M.J. and Stricker, E.M. (1974) Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes, ed. by E. Usdin, Raven Press, New York, pp.385–402.
Zigmond, R.E. (1979) J. Neurochem., 32, 23–29.
Zigmond, R.E., Chalazonitis, A., Joh, T. (1981) Neuroscience Letters, 20, 61–65.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1981 The Contributors
About this chapter
Cite this chapter
Zigmond, M.J., Acheson, A.L., Stricker, E.M. (1981). Partial destruction of noradrenergic terminals is followed by increased tyrosine hydroxylase activity in residual terminals. In: Usdin, E., Weiner, N., Youdim, M.B.H. (eds) Function and Regulation of Monoamine Enzymes: Basic and Clinical Aspects. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06276-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-349-06276-8_14
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06278-2
Online ISBN: 978-1-349-06276-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)